FEBCX
Price
$15.50
Change
+$0.04 (+0.26%)
Updated
Oct 3 closing price
Net Assets
2.11B
RIRBX
Price
$79.82
Change
+$0.32 (+0.40%)
Updated
Oct 3 closing price
Net Assets
119.9B
Interact to see
Advertisement

FEBCX vs RIRBX

Header iconFEBCX vs RIRBX Comparison
Open Charts FEBCX vs RIRBXBanner chart's image
First Eagle Global Income Builder C
Price$15.50
Change+$0.04 (+0.26%)
VolumeN/A
Net Assets2.11B
American Funds Capital Income Bldr R2
Price$79.82
Change+$0.32 (+0.40%)
VolumeN/A
Net Assets119.9B
FEBCX vs RIRBX Comparison Chart in %
View a ticker or compare two or three
VS
FEBCX vs. RIRBX commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEBCX is a Hold and RIRBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 120B vs. FEBCX (2.11B). RIRBX pays higher dividends than FEBCX: RIRBX (2.20) vs FEBCX (1.58). FEBCX was incepted earlier than RIRBX: FEBCX (13 years) vs RIRBX (23 years). FEBCX (1.94) is less costly to investors than RIRBX (1.36). RIRBX is a more actively managed with annual turnover of: 56.00 vs. FEBCX (14.66). RIRBX has a lower initial minimum investment than FEBCX: RIRBX (250) vs FEBCX (2500). FEBCX annual gain was more profitable for investors over the last year : 12.57 vs. RIRBX (11.69). RIRBX return over 5 years is better than : 51.07 vs. FEBCX (43.44).
FEBCXRIRBXFEBCX / RIRBX
Total Expense Ratio1.941.36143%
Annual Report Gross Expense Ratio1.941.36143%
Fund Existence13 years23 years-
Gain YTD19.50217.095114%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B120B2%
Annual Yield % from dividends1.582.2072%
Returns for 1 year12.5711.69108%
Returns for 3 years40.3942.5995%
Returns for 5 years43.4451.0785%
Returns for 10 years70.3959.00119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIN55.411.81
+3.38%
Albany International Corp
CLLS3.500.08
+2.34%
Cellectis SA
KPTI6.380.09
+1.43%
Karyopharm Therapeutics Inc.
AGCO108.641.22
+1.14%
AGCO Corp
TCBIO21.750.10
+0.46%
Texas Capital Bancshares